Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
7.59
-0.31 (-3.92%)
At close: Feb 21, 2025, 4:00 PM
7.85
+0.26 (3.43%)
After-hours: Feb 21, 2025, 6:05 PM EST
Contineum Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$29.25
Upside
+285.38%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +308.43% | Jan 9, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $32 → $31 | Buy | Maintains | $32 → $31 | +308.43% | Nov 7, 2024 |
| Baird | Baird | Buy Initiates $32 | Buy | Initiates | $32 | +321.61% | Oct 22, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $30 → $32 | Buy | Maintains | $30 → $32 | +321.61% | Aug 14, 2024 |
| Stifel | Stifel | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +282.08% | Apr 30, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $30 | Buy | Initiates | $30 | +295.26% | Apr 30, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $25 | Buy | Initiates | $25 | +229.38% | Apr 30, 2024 |